(last updated January 23 2024 @ 2:14 pm)
East Side Pediatrics, on Providence's historic College Hill, is a primary care pediatric office caring for children from birth to 21 years old. We are a NCQA-certified Patient-Centered Medical Home (PCMH) providing comprehensive and coordinated care that focuses on families.
Our doctors are members of the American Academy of Pediatrics and are board-certified by the American Board of Pediatrics. Academic rigor keeps our doctors from having stagnant medical knowledge.
Knowledge is not enough, though. Our providers understand the importance of bedside manner. We always consider things from both a doctor's and parent's perspective. We love taking care of children and treat patients as if taking care of our own.
Beyfortus is not yet available in our office. This space will be updated when it is available in our office.
Beyfortus, the new anti-RSV immunoglobulin is an injection that has the potential to significantly decrease the burden of RSV in infants, reducing hospitalization and death (CDC information statement here). It is intended for all new babies born during RSV season (November 1, 2023 through March 31, 2024) in the first week of life. The newest CDC guidelines (Oct 23, 2023) also recommend this immunization for infants born before November 1, 2023, at the highest risk for severe disease (healthy infants < 6 months old and infants < 8 months old with underlying conditions that put them at high risk for severe disease*).
Beyfortus is not available for infants 8 months old or older. Infants who have turned 8 months old or are older and are at high risk for severe disease* may be eligible for Synagis. In general, these babies would have received Synagis during the 2022-2023 RSV season.
When Beyfortus is available in our office we will:
There is nothing you need to do now. We have a data set with all patients who meet criteria for Beyfortus and Synagis. There has been considerable delay in the release of this immunization due to limited supply nationally. We are waiting to receive Beyfortus through the Rhode Island Department of Health are anticipating receiving it in mid-to-late November.
*The following conditions pose a high-risk for severe RSV disease:
Our board-certified doctors have decades of combined experience in Southeastern New England. And they are parents themselves. Find out more!
You may now request medication refills or referrals through our portal in a HIPPA-compliant environment.
There is a great deal of medical information on the internet, only some of it reliable. Look up diagnoses, get medication dosages,
follow useful links, become better informed!